Skip to main content

University of Michigan

University of Michigan
Ann Arbor, Michigan
SOURCE: SPIROMICS Study of Early COPD Progression is looking for people who have never smoked cigarettes, people who are current cigarette smokers, and people who are former cigarette smokers between 30 and 55 years old to participate in a research study on early signs of lung disease. Most studies of lung disease and Chronic Obstructive Pulmonary Disease (COPD) involve older people. This 5-year study at 14 sites across the U.S. will help us better understand COPD in younger people. You do not need a COPD diagnosis to join.

Study Site Location

Michigan Medicine
Michigan Clinical Research Unit (MCRU)
Frankel Cardiovascular Center, Floor 1
1500 East Medical Center Drive
Ann Arbor, MI 48130

(734) 647-6399
SOURCE study principal investigator MeiLan Han, MD, MS
MeiLan Han, MD, MS
Principal Investigator
The COVID-19 pandemic has made the world more aware of the importance of lung health than ever. This study offers participants an opportunity to better understand their own lung health and for researchers to better understand factors that contribute to lung health and disease.
Crystal Cutlip Portrait
Crystal Cutlip
Clinical Research Coordinator

Are you eligible to join?

Never smokers, as well as current and former cigarette smokers are eligible. No COPD diagnosis is necessary. Answer the screening questions by entering your age and the numbers of years smoked(enter 0 if you have never smoked). If you are eligible, you’ll be asked for your contact information. By submitting your contact information you’re agreeing to be contacted about this study.

Smokers and non-smokers between the ages of 30 and 55 may qualify for this study on early COPD.